Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer
Clinical trial NCT01498562 · COMPLETED
Trial details
- NCT number
- NCT01498562
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.